Shots: The agreement will focus on commercialization of kidney organoid technology, for generation of human pluripotent stem cell-derived kidney organoids This technology enables the growth of organoids/ mini-organs, having key features of renal development and physiology in vitro and is developed by one of the professor at Brigham and Women’s Hospital The kidney organoids provide […]Read More
